Table 2. Characteristic oscillatory changes during dexmedetomidine-induced altered behavioral states.
| Behavioral state | Slow-Delta | Alpha | Beta | Spindle activity | |
|---|---|---|---|---|---|
| Wakefulness | minimal | absent | high | absent |
Figure 2B,C,E,F
Figure 4B |
| LOC | high with delay | transiently high | minimal | high | |
| Unresponsiveness | high | low | absent | high | |
| ROC | minimal* | high | absent | high | |
| ROPAP | minimal | minimal | high | minimal | |
| Arousal by external stimuli after LOC during dexmedetomidine infusion | minimal | transiently high | absent | NA | Figure 2H |
| Reversal by α2-adrenergic antagonist during dexmedetomidine infusion | minimal | absent | high | absent | Figure 5B,C,E,F,G |
Note: The characteristic changes of the frequency band power and spindle activity are summarized for each behavioral endpoint. *The slow-delta power was diminished at ROC, but frequently reappeared through early recovery until ROPAP.